- Name
- Hwabao WP Hang Seng SCHK Innovative Drug Select ETF
- Index tracked
- Hang Seng SCHK Innovative DrugSel PR CNY
- Type
- Equity
- Management fee
- 0.5%
- Dividend policy
- Monthly
- NAV
- CNY 0.4385 (07/29/2026)
- Issued units
- 5.73B (06/30/2026)
- Listing date
- Jun 27, 2025
- Sponsor
- Hwabao WP Fund Management Co.,Ltd
- Custodian
- Guosen Securities Co Ltd